Literature DB >> 36106538

The intestine is a major contributor to circulating succinate in mice.

Wenxin Tong1,2, Sarah A Hannou2, You Wang2, Inna Astapova2,3, Ashot Sargsyan2, Ruby Monn2, Venkataramana Thiriveedi4, Diana Li4, Jessica R McCann5, John F Rawls5, Jatin Roper1,4, Guo-Fang Zhang2, Mark A Herman2,3.   

Abstract

The tricarboxylic acid (TCA) cycle is the epicenter of cellular aerobic metabolism. TCA cycle intermediates facilitate energy production and provide anabolic precursors, but also function as intra- and extracellular metabolic signals regulating pleiotropic biological processes. Despite the importance of circulating TCA cycle metabolites as signaling molecules, the source of circulating TCA cycle intermediates remains uncertain. We observe that in mice, the concentration of TCA cycle intermediates in the portal blood exceeds that in tail blood indicating that the gut is a major contributor to circulating TCA cycle metabolites. With a focus on succinate as a representative of a TCA cycle intermediate with signaling activities and using a combination of gut microbiota depletion mouse models and isotopomer tracing, we demonstrate that intestinal microbiota is not a major contributor to circulating succinate. Moreover, we demonstrate that endogenous succinate production is markedly higher than intestinal succinate absorption in normal physiological conditions. Altogether, these results indicate that endogenous succinate production within the intestinal tissue is a major physiological source of circulating succinate. These results provide a foundation for an investigation into the role of the intestine in regulating circulating TCA cycle metabolites and their potential signaling effects on health and disease.
© 2022 Federation of American Societies for Experimental Biology.

Entities:  

Keywords:  TCA cycle intermediates; circulating biomarkers; intestine; succinate

Mesh:

Substances:

Year:  2022        PMID: 36106538      PMCID: PMC9523828          DOI: 10.1096/fj.202200135RR

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.834


  48 in total

1.  Composition and metabolic activities of bacterial biofilms colonizing food residues in the human gut.

Authors:  Sandra Macfarlane; George T Macfarlane
Journal:  Appl Environ Microbiol       Date:  2006-09       Impact factor: 4.792

2.  Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche.

Authors:  Toshiro Sato; Robert G Vries; Hugo J Snippert; Marc van de Wetering; Nick Barker; Daniel E Stange; Johan H van Es; Arie Abo; Pekka Kujala; Peter J Peters; Hans Clevers
Journal:  Nature       Date:  2009-03-29       Impact factor: 49.962

Review 3.  Gut Microbiota in Cardiovascular Health and Disease.

Authors:  W H Wilson Tang; Takeshi Kitai; Stanley L Hazen
Journal:  Circ Res       Date:  2017-03-31       Impact factor: 17.367

4.  Detection of Succinate by Intestinal Tuft Cells Triggers a Type 2 Innate Immune Circuit.

Authors:  Marija S Nadjsombati; John W McGinty; Miranda R Lyons-Cohen; James B Jaffe; Lucian DiPeso; Christoph Schneider; Corey N Miller; Joshua L Pollack; G A Nagana Gowda; Mary F Fontana; David J Erle; Mark S Anderson; Richard M Locksley; Daniel Raftery; Jakob von Moltke
Journal:  Immunity       Date:  2018-07-17       Impact factor: 31.745

5.  Surface area assessment of the murine intestinal tract as a prerequisite for oral dose translation from mouse to man.

Authors:  C Casteleyn; A Rekecki; A Van der Aa; P Simoens; W Van den Broeck
Journal:  Lab Anim       Date:  2009-12-10       Impact factor: 2.471

6.  Triggering the succinate receptor GPR91 on dendritic cells enhances immunity.

Authors:  Tina Rubic; Günther Lametschwandtner; Sandra Jost; Sonja Hinteregger; Julia Kund; Nicole Carballido-Perrig; Christoph Schwärzler; Tobias Junt; Hans Voshol; Josef G Meingassner; Xiaohong Mao; Gudrun Werner; Antal Rot; José M Carballido
Journal:  Nat Immunol       Date:  2008-09-28       Impact factor: 25.606

Review 7.  Fructose metabolism and metabolic disease.

Authors:  Sarah A Hannou; Danielle E Haslam; Nicola M McKeown; Mark A Herman
Journal:  J Clin Invest       Date:  2018-02-01       Impact factor: 14.808

8.  Elevated circulating levels of succinate in human obesity are linked to specific gut microbiota.

Authors:  Carolina Serena; Victoria Ceperuelo-Mallafré; Noelia Keiran; Maria Isabel Queipo-Ortuño; Rosa Bernal; Ricardo Gomez-Huelgas; Mireia Urpi-Sarda; Mónica Sabater; Vicente Pérez-Brocal; Cristina Andrés-Lacueva; Andres Moya; Francisco J Tinahones; Jose Manuel Fernández-Real; Joan Vendrell; Sonia Fernández-Veledo
Journal:  ISME J       Date:  2018-02-12       Impact factor: 10.302

9.  A core gut microbiome in obese and lean twins.

Authors:  Peter J Turnbaugh; Micah Hamady; Tanya Yatsunenko; Brandi L Cantarel; Alexis Duncan; Ruth E Ley; Mitchell L Sogin; William J Jones; Bruce A Roe; Jason P Affourtit; Michael Egholm; Bernard Henrissat; Andrew C Heath; Rob Knight; Jeffrey I Gordon
Journal:  Nature       Date:  2008-11-30       Impact factor: 49.962

Review 10.  Succinate as a Regulator of Hepatic Stellate Cells in Liver Fibrosis.

Authors:  Eun-Hee Cho
Journal:  Front Endocrinol (Lausanne)       Date:  2018-08-21       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.